Note from the Director
Date: March 21, 2011
A Note from the Director
This is truly an exciting time to be a part of cancer medicine, and Maryland is on the forefront. Scientific breakthroughs by our investigators have revealed the unique genetic profiles for 88 types of cancer, including colon, breast, pancreatic, and brain cancers. This research, funded in part by the Maryland Cigarette Restitution Fund, has allowed us to begin altering the course of cancer in ways we could only imagine a few decades ago.
For the first time, we can begin to provide patients personalized therapies that target the unique cellular mistakes that initiate and drive their individual cancers. This new approach not only improves treatment outcomes but will also allow us to prevent many people from ever developing a cancer. It gives us the ability to accurately predict what drugs will work on which patients, and can tell us who needs regular cancer screening, and most importantly, who can be spared. The research supported by CRF improves care and has the potential to dramatically slash health care costs.
With this in mind, we cannot imagine a more appropriate partner in this work than the state of Maryland. As you can see, CRF programs have not only contributed to the health of Maryland citizens but also to the health of the state economy. We appreciate the continued commitment by our Governor and State lawmakers in the face of such difficult economic times. Every CRF dollar we receive is put to good use making cancer detection and treatment more effective and more efficient. CRF grants are critical to helping launch the research projects of bright, young faculty, who are then able to parlay this work into millions more in grants from other sources. We look forward to returning to full funding of the CRF research grant because while there is much we have accomplished together, we realize that until every patient is cured, there is still work left to do.
William G. Nelson, M.D., Ph.D.
Marion I. Knott Professor and Director
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins